- Home
- BKV vs CLVT Comparison
BKV vs CLVT Comparison
Compare BKV & CLVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BKV | CLVT |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | EDP Services |
| Sector | Energy | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | BKV | CLVT |
|---|---|---|
| Price | $26.91 | $3.34 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 4 |
| Target Price | ★ $30.29 | $4.50 |
| AVG Volume (30 Days) | 965.3K | ★ 5.3M |
| Earning Date | 11-10-2025 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | $822,525,000.00 | ★ $2,501,200,000.00 |
| Revenue This Year | $56.14 | N/A |
| Revenue Next Year | $40.45 | N/A |
| P/E Ratio | $51.68 | ★ N/A |
| Revenue Growth | ★ 33.41 | N/A |
| 52 Week Low | $15.00 | $3.04 |
| 52 Week High | $29.65 | $5.74 |
Technical Indicators
Market Signals| Indicator | BKV | CLVT |
|---|---|---|
| Relative Strength Index (RSI) | 50.49 | 43.00 |
| Support Level | $26.98 | $3.28 |
| Resistance Level | $28.21 | $3.54 |
| Average True Range (ATR) | 0.89 | 0.15 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 39.78 | 18.57 |
Price Performance
Historical ComparisonAbout BKV BKV Corporation
BKV Corp is a growth-driven energy company. Its core business is production of natural gas from its owned and operated upstream businesses. It operates in four business lines: natural gas production, natural gas gathering, processing and transportation (natural gas midstream business), power generation and carbon capture, utilization, and sequestration (CCUS).
About CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.